HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulation of T cell trafficking by the T cell immunoglobulin and mucin domain 1 glycoprotein.

Abstract
Leukocyte trafficking is generally considered the initial stage of any immune response, and it involves a multistep intravascular process including capture, rolling, activation, arrest, crawling, and transmigration. Both capture and rolling are predominantly mediated by selectins, which allow circulating leukocytes to sense activating signals on the endothelium and adhere to vessel walls. In this review, we discuss recent data showing that the T cell immunoglobulin and mucin domain 1 (TIM-1) protein is a major ligand for endothelial P-selectin, mediating T helper (Th) cell Th1 and Th17 trafficking in inflamed tissues. We highlight structural and functional features showing that TIM-1 can be included in the restricted group of major adhesion receptors involved in leukocyte trafficking with a pathophysiological role in inflammation and autoimmunity.
AuthorsStefano Angiari, Gabriela Constantin
JournalTrends in molecular medicine (Trends Mol Med) Vol. 20 Issue 12 Pg. 675-84 (Dec 2014) ISSN: 1471-499X [Electronic] England
PMID25457618 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • HAVCR1 protein, human
  • Hepatitis A Virus Cellular Receptor 1
  • Ligands
  • Membrane Glycoproteins
  • P-selectin ligand protein
  • Receptors, Virus
  • Selectins
Topics
  • Animals
  • Autoimmunity (immunology)
  • Disease Models, Animal
  • Hepatitis A Virus Cellular Receptor 1
  • Humans
  • Inflammation (immunology)
  • Leukocyte Rolling
  • Ligands
  • Lymphocyte Activation
  • Membrane Glycoproteins (immunology)
  • Receptors, Virus (immunology)
  • Selectins (immunology)
  • T-Lymphocytes (immunology)
  • Th1 Cells (immunology)
  • Th17 Cells (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: